Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0065 EUR | 0.00% | +8.33% | -35.00% |
2021 | Ovoca Bio : Enrolls First Patient in Phase 2 Trial for Hypoactive Sexual Desire Disorder Treatment | MT |
Sales 2021 | - | Sales 2022 | - | Capitalization | 4.89M 4.51M |
---|---|---|---|---|---|
Net income 2021 | -5M -4.61M | Net income 2022 | -5M -4.61M | EV / Sales 2021 | - |
Net cash position 2021 | 6.59M 6.08M | Net cash position 2022 | 3.7M 3.41M | EV / Sales 2022 | - |
P/E ratio 2021 |
-2.23
x | P/E ratio 2022 |
-0.87
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 47.54% |
1 week | +8.33% | ||
Current month | +8.33% | ||
1 month | +8.33% | ||
3 months | -55.17% | ||
6 months | -56.67% | ||
Current year | -35.00% |
Date | Price | Change |
---|---|---|
24-05-24 | 0.0065 | 0.00% |
24-05-23 | 0.0065 | 0.00% |
24-05-22 | 0.0065 | 0.00% |
24-05-21 | 0.0065 | +8.33% |
24-05-20 | 0.006 | 0.00% |
Real-time Irish S.E., May 24, 2024 at 11:55 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-35.00% | 575K | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- OVXA Stock